Polymeric compounds containing piperidine radicals and their use as stabilizers for synthetic polymers

ABSTRACT

Novel light stabilizers, heat stabilizers and oxidation stabilizers for synthetic polymers have been synthesized; these are of the formula: ##STR1## in which R 3  and R 4  can be identical or different and are radicals of formula (III), (IV), (V), (VI) ##STR2## and R 5  additionally can be a radical of formula VII ##STR3## and R 4  is C 2  -C 18  -diacyl or a radical of the formula ##STR4##

This is a divisional of application Ser. No. 652,631 filed on Sept. 20, 1984, now U.S. Pat. No. 4,696,961.

The present invention relates to novel polymeric compounds which contain piperidine radicals and can be used as light stabilisers, heat stabilisers and oxidation stabilisers for synthetic polymers, and to the process for their preparation.

Hydroxyl groups containing polyethers carrying polyalkylpiperidylamino groups are disclosed in U.S. Pat. No. 4,294,963 as stabilizers for polymers. New triazine piperidylethers have now been found which show an outstanding effectiveness in improving the light stability of synthetic polymers.

In particular, the present invention relates to novel compounds of the formula ##STR5## in which R₁ and R₂ can be identical or different and are hydrogen, C₁ -C₁₈ -alkyl, C₂ -C₁₂ -alkyl substituted by --OH, a C₁ -C₁₈ -alkoxy group or a C₂ -C₁₈ -dialkylamino group, C₃ -C₁₈ -alkenyl, C₅ -C₁₈ -cycloalkyl, C₆ -C₁₈ -aryl, C₇ -C₁₈ -aralkyl or a radical of the formula ##STR6## where R₆ is hydrogen, C₁ -C₁₂ -alkyl, C₃ -C₁₂ -alkenyl or -alkynyl, C₇ -C₁₂ -aralkyl or C₁ -C₁₂ -acyl, or R₁ and R₂, together with the nitrogen atom to which they are bonded, are a heterocyclic radical, such as pyrrolidin-1-yl, piperidin-1-yl, hexahydroazepin-1-yl, morpholin-4-yl or 4-methylpiperazin-1-yl, R₃ and R₅ can be identical or different and are radicals of the formula (III), (IV), (V) or (VI) ##STR7## and R₅ additionally can be a radical of formula VII ##STR8## wherein R₇ is hydrogen, C₁ -C₆ -alkyl or phenyl, X is a group --O--CH₂)_(n) O-- or --N(R₈)--C(O)- CH₂)_(n) C(O)--N(R₈)--, n is a number between 1 and 6, R₈ has the same meaning as R₁ or R₂ and Y is C₂ -C₁₂ -alkylene, C₃ -C₁₂ -alkylene substituted by one hydroxyl or containing an oxgen atom in the chain, C₄ -C₁₂ -alkenylene or C₈ -C₁₂ aralkylene, R₄ is C₂ -C₁₈ -diacyl or a radical of the formula (VIII) ##STR9## in which R₁ and R₂ are as defined above, a is a number between 0.2 and 1, and b is a number between zero and 0.8; the compounds of the formula (I) have a number average molecular weight Mn between 1,000 and 20,000.

The meanings of the radicals present in the compounds of the formula (I) are: for

R₁, R₂ and R8: hydrogen, methyl, ethyl, propyl, isopropyl, butyl, but-2-yl, isobutyl, hexyl, 2-ethylhexyl, octyl, decyl, dodecyl, hexadecyl, octadecyl, 2-hydroxyethyl, 3-hydroxypropyl, 2-methoxyethyl, 2-ethoxyethyl, 3-methoxpropyl, 3-ethoxypropyl, 3-octyloxypropyl, 3-dodecyloxypropyl, 3-octadecyloxypropyl, 3-dimethylaminopropyl, 3-diethylaminopropyl, 4-diethylaminobutyl, allyl, methallyl, but-2-enyl, undec-10-enyl, oleyl, cyclohexyl, methylcyclohexyl, trimethylcyclohexyl, cyclooctyl, cyclododecyl, phenyl, methylphenyl, dimethylphenyl, trimethylphenyl, t-butylphenyl, t-octylphenyl, methoxyphenyl, ethoxyphenyl, 3,5-di-t-butyl-4-hydroxyphenyl, benzyl, methylbenzyl, hydroxybenzyl, 3,5-di-t-butyl4-hydroxybenzyl, 2,2,6,6-tetramethyl-piperidin-4-yl, 1,2,2,6,6-pentamethyl-piperidin-4-yl, 1-allyl-2,2,6,6-tetramethyl-piperidin-4-yl, 1-benzyl-2,2,6,6-tetramethyl-piperidin-4-yl and 1-acetyl 2,2,6,6-tetramethyl-piperidin-4-yl;

for R₄ : oxalyl, malonyl, succinyl, glutaryl, adipoyl, sebacoyl, isophthaloyl, terephthaloyl or a radical of the formula (V) in which R₁ and R₂ have the preferred meanings defined above;

for R₆ : hydrogen, methyl, ethyl, propyl, butyl, hexyl, octyl, decyl, dodecyl, allyl, methallyl, but-2-enyl, hex-2-enyl, propargyl, benzyl, methylbenzyl, t-butylbenzyl, hydroxybenzyl, acetyl, propionyl, butryl, caproyl and benzoyl;

for R₇ : hydrogen, methyl, ethyl, propyl, butyl, hexyl and phenyl, for Y: ethylene, trimethylene, tetramethylene, hexamethylene, octamethylene, decamethylene, dodecamethylene, 2-hydroxypropane1,3-diyl, 3-oxapentane-1,5-diyl, but-2-ene-1,4-diyl and xylylene.

Compounds of the formula (I) which have given particularly interesting results are those in which R₁ and R₂ can be identical or different and are hydrogen, C₁ -C₁₂ -alkyl, C₂ -C₆ -alkyl substituted by C₁ -C₁₂ -alkoxy, C₃ -C₆ -alkenyl, C₆ -C₁₀ -cycloalkyl or a radical of the formula (II) in which R₆ is hydrogen, methyl, allyl, benzyl or acetyl, or the radicals R₁ and R₂, together with the nitrogen atom to which they are bonded, are a pyrrolidin-1-yl, piperidin-1-yl, hexahydroazepin-1-yl or morpholin-4-yl radical, R₃ and R₅ are a radical of formula (III) and R₅ additionally can be a radical of formula (VII), R₇ is hydrogen, methyl, or ethyl, Y is C₂ -C₆ -alkylene, but-2-ene-1,4-diyl or xylylene, R₄ is C₂ -C12-diacyl or a radical of the formula (VIII) in which R₁ and R₂ are as defined above, a is a number between 0.3 and 1, and b is a number between zero and 0.7, and the number average molecular weight Mn is between 1,500 and 10,000.

Compounds of the formula (I) which are preferred for the use according to the present invention are those in which R₁ and R₂ can be identical or different and are C₁ -C₈ -alkyl, cyclohexyl, 2,2,6, 6-tetramethyl-piperidin-4-yl or 1,2;2,6,6-pentamethyl-piperidin-4-yl, R3 and R₅ are a radical of formula (III) and R₅ additionally can be a radical of formula (VII), R₇ is hydrogen or methyl, Y is but-2-ene-1,4-diyl or xylylene, a is 1 and b is zero, and the number average molecular weight Mn is between 1,500 and 6,000.

If b is other than zero, the compounds of the formula (I) can be prepared by reacting a mixture of the compounds of the formula (IX) and (X) ##STR10## in which R₁, R₂ and R₄ are as defined above and A₁, A₂, A₃ and A₄ are Cl or C₁ -C₄ -alkoxy, with a compound of formula (XI), (XII), (XIII) or (XIV) ##STR11## and, if R₅ is a radical of formula VII, additionally with a compound of formula XV ##STR12## wherein R₇, X and Y are as defined above, preferably in a stoichiometric ratio.

If b is zero, the compounds of the formula (I) are prepared by reacting a compound of the formula (IX) with a compound of formula (XI), (XII), (XIII) or (XIV) and optionally (XV) in an approximately stoichiometric ratio.

In both cases, the reaction can be effected in the presence or absence o an inert organic solvent and in the presence of an organic or inorganic base, if A₁, A₂, A₃ and ₄ are Cl, or in the presence of a transesterification catalyst, if A₁, A₂, A₃ and A₄ are alkoxy groups.

Inert organic solvents suitable for use as reaction media are, for example, benzene, toluene, xylene, ethylbenzene, trimethylbenzene, tetralin, decalin, octane, decane, mixtures of aliphatic hydrocarbons having boiling points between 100° and 200° C., dioxane, dibutyl ether, 1,2-dimethoxyethane, 1,2-diethoxyethane, diethylene glycol dimethyl ether and diethylene glycol diethyl ether.

To fix the hydrochloric acid liberated in the process, if reagents are used in which A₁, A₂, A₃ and A₄ are Cl, suitable organic and inorganic bases are, for example, pyridine, triethylamine, tributylamine, sodium hydroxide, potassium hydroxide, sodium carbonate or potassium carbonate; in every case the base is used in a quantity almost equivalent to the hydrohalic acid liberated in the reaction.

In the case where A₁, A₂, A₃ and A₄ are alkoxy groups, examples of transesterification catalysts which can be used are alkali metals and alcoholates, hydrides and amides of alkali metals.

The polycondensation reactions can be effected at temperatures between 80° and 280° C., preferably betwen 100° and 200°, in a molar ratio (compound of the formula (IX)+compound of the formula (X): (compound of the formula (XI), (XII), (XIII) or (XIV)+compound of the formula (XV) of between 1.3:1 and 1:1.3, preferably between 1.2:1 and 1:1.2.

The various reagents can be introduced into the reaction simultaneously or in successive phases.

The compounds of the formula (IX) can be obtained by known processes, starting from cyanuric chloride; the dichloro-triazines or dialkoxy-triazines prepared can be employed directly without isolation in the reaction mixture, or after isolation. The compounds of formula (XI), (XII), (XIII), (XIV) and (XV) are known compounds.

In order to illustrate the present invention more clearly, several examples of the preparation of compounds of the formula (I) are described below; these examples are given by way of illustration only and do not imply any restriction.

EXAMPLE 1

35.1 g (0.1 mole) of 2-[N-(2,2,6,6-tetramethylpiperidin4-yl)-butylamino]-4,6-dimethoxy-1,3,5-triazine, 20.1 g (0.1 mole) of 1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol, 0.3 g of sodium hydride and 200 ml of xylene are heated under reflux for 12 hours, the solvent being slowly distilled off, together with the methanol liberated during the reaction, and being replaced with an equal volume of fresh solvent.

The reaction mixture is evaporated to dryness and the residue obtained is ground, washed with water and dried.

The product obtained has a melting point of 205°-215° C. and a number average molecular weight Mn of 4,300.

EXAMPLES 2 and 3

The procedure described in Example 1 is repeated for the preparation of other compounds of the formula (I) from the reagents specified below and in the indicated ratios.

    __________________________________________________________________________                                          Product                                                                             melting                              Example                                                                             Reagents                        --Mn point                                __________________________________________________________________________           ##STR13##                                                                                       ##STR14##     3200 160-172° C.                        38.1 g  (0.1 m)  20.1 g  (0.1 m)                                          3                                                                                    ##STR15##                                                                                       ##STR16##     1800 152-160° C.                        21.2 g  (0.1 m)  20.1 g  (0.1 m)                                          __________________________________________________________________________

EXAMPLE 4

26,8 g (0.1 mole) of 4-octylamino-2,2,6,6-tetramethylpiperidine are added slowly, while not exceeding 10° C., to a solution of 18.5 g (0.1 mole) of cyanuric chloride in 180 ml of trimethylbenzene, cooled to 0° C.

A solution of 4 g of sodium hydroxide in 50 ml of water is then added, while maintaining the temperature at 10° C.

To the mixture thus obtained, 20.1 g (0.1 mole) of 1-(2-hydroxy- ethyl)-2,2,6,6-teramethyl-piperidin-4-ol and 12 g of sodium hydroxide are added, and the mixture is heated under reflux for 20 hours with azeotropic removal of the water.

After filtration, in order to separate off the inorganic products, and after removal of the solvent, a product is obtained which melts at 145°-152° C. and has a number average molecular weight Mn of 2200.

EXAMPLES 5-6

The procedure described in Example 4 is repeated for the preparation of two further compounds of the formula (I) from the reagents specified below and in the indicated ratios:

    __________________________________________________________________________                                                       Product                      Example                                                                              Reagents                                    --Mn  melting                __________________________________________________________________________                                                             point                         ##STR17##                                                                                ##STR18##                                                                                        ##STR19##      1600  125-136°                                                                C.                           18.5 g  (0.1 m)                                                                          26.8 g  (0.1 m)   21.5 g  (0.1 m)                              6                                                                                     ##STR20##                                                                                ##STR21##                                                                                        ##STR22##      2450  210-220°                                                                C.                           18.5 g  (0.1 m)                                                                          21.2 g  (0.1 m)   31.2 g  (0.1 m)                              __________________________________________________________________________

EXAMPLE 7

20.4 g (0.05 mole) of 2,4-dimethoxy-6-[N-(2,2,6,6-tetramethyl-piperidin-4-yl)-octylamino]-1,3,5-triazine, and 20.1 g (0.1 mole) of 1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol, (0.25 g of sodium and 200 ml of xylene are heated under reflux for 8 hours, the solvent being distilled off, together with the methanol produced during the reaction, and being replaced by an equal volume of fresh xylene.

The mixture is cooled to 80° C., and 7.3 g (0.05 mole) of dimethyl succinate are added, and the mixture is heated under reflux for a further 8 hours with continuing replacement of the solvent.

After the end of the reaction, the mixture is diluted with 200 ml of xylene and filtered, and the filtrate is evaporated to dryness. The product obtained melts at 95°-103° C. and has a number average molecular weight Mn of 3,700.

EXAMPLE 8

Using the same procedure as that described in Example 7, a copolymer is prepared, using 17.55 g (0.05 mole) of 2-[N-(2,2,6,6-tetramethyl-piperidin-4-yl)-butylamino]-4,6-dimethoxy-1,3,5-triazine, 20.1 g (0.1 mole) of 1-(2-hydroxyethyl)-2,2,6,6-tetramethyl- piperidin-4-ol and 7.3 g (0.05 mole) of dimethyl succinate as the reagents.

The product obtained melts at 125°-134° C. and has a number average molecular weight Mn of 2,000.

As mentioned at the outset, the compounds of the formula (I) are very effective in improving the light stability, heat stability and oxidation stability of synthetic polymers, for example high-density and low-density polyethylene, polypropylene, ethylene/propylene copolymers, ethylene vinyl acetate copolymers, poylbutadiene, polyisoprene, polystyrene, butadiene/styrene copolymers, vinyl chloride/vinylidene chloride polymers and copolymers, polyoxymethylene, polyurethanes, saturated and unsaturated polyesters, polyamides, polycarbonates, polyacrylates, alkyd resins and epoxide resins.

The compounds of the formula (I) can be mixed with the synthetic polymers in various proportions depending on the nature of the polymer, the end use and the presence of other additives. In general, it is advantageous to employ from 0.01 to 5% by weight of the compounds of the formula (I), relative to the weight of the polymers, preferably from 0.05 to 1%.

The compounds of the formula (I) can be incorporated into the polymeric materials by various processes, such as dry blending in the form of powders, or wet mixing in the form of solutions or suspensions, or mixing in the form of a masterbatch; in these operations, the synthetic polymer can be employed in the form of powder, granules, a solution, a suspension or in the form of a latex.

The polymers stabilised with the products of the formula (I) can be used for the preparation of moulded articles, films, tapes, fibres, monofilaments, surface-coatings and the like.

If desired, other additives, such as antioxidants, ultraviolet absorbers, nickel stabilisers, pigments, fillers, plasticisers, antistatic agents, flameproofing agents, lubricants, anti-corrosion agents and metal deactivators, can be added to the mixtures of the compounds of the formula (I) with the synthetic polymers.

Examples of additives which can be mixed with the compounds of the formula (I) are, in particular:

1 Antioxidants

1.1. Alkylated monophenols, for example,

2,6-di-tert.butyl-4-methylphenol

2-tert.butyl-4,6-dimethylphenol

2,6-di-tert.butyl-4-ethylphenol

2,6-di-tert.butyl-4-n-butylphenol

2,6-di-tert.butyl-4-i-butylphenol

2,6-di-cyclopentyl-4-methylphenol

2-(αmethylcyclohexyl)-4,6-dimethylphenol

2,6-di-octadecyl-4-methylphenol

2,4,6-tri-cyclohexylphenol

2,6-di-tert.butyl-4-methoxymethylphenol

1.2. Alkylated hydroquinones, for example,

2,6-di-tert.butyl-4-methoxyphenol

2,5-di-tert.butyl-hydroquinone

2,5-di-tert.amyl-hydroquinone

2,6-diphenyl-4-octadecyloxyphenol

1.3. Hydroxylated thiodiphenyl ethers, for example

2,2'-thio-bis-(6-tert.butyl-4-methylphenol)

2,2'-thio-bis-(4-octylphenol)

4,4'-thio-bis-(6-tert.butyl-3-methylphenol)

4,4'-thio-bis-(6-tert.butyl-2-methylphenol)

1.4. Alkyliden-bisphenols, for example,

2,2'-methylene-bis-(6-tert.butyl-4-methylphenol)

2,2'-methylene-bis-(6-tert.butyl-4-ethylphenol)

2,2'-methylene-bis-[4-methyl-6-(α-methylcyclohexyl)-phenol]

2,2'-methylene-bis-(4-methyl-6-cyclohexylphenol)

2,2'-methylene-bis-(6-nonyl-4-methylphenol)

2,2'-methylene-bis-[6-(α-methylbenzyl)4-nonylphenol]

2,2'-methylene-bis-[6-(α,α-dimethylbenzyl)-4-nonylphenol]

2,2'-methylene-bis-(4,6-di-tert.butylphenol)

2,2'-ethylidene-bis-(4,6-di-tert.butylphenol)

2,2'-ethylidene-bis-(6-tert.butyl-4-isobutylphenol)

4,4'-methylene-bis-(2,6-di-tert.butylphenol)

4,4'-methylene-bis-(6-tert.butyl-2-methylphenol)

1,1-bis-(5-tert.butyl-4-hydroxy-2-methylphenyl)-butane

2,6-di-(3-tert.butyl-5-methyl-2-hydroxybenzyl)-4-methylphenol

1,1,3-tris-(5-tert.butyl-4-hydroxy-2-methylphenyl)-butane

1,1-bis-(5-tert.butyl-4-hydroxy-2-methylphenyl)-3-n-dodecylmercaptobutane

ethylenglycol-bis-[3,3-bis-(3'-tert.butyl-4'-hydroxyphenyl)-butyrat]

di-(3-tert.butyl-4-hydroxy-5-methylphenyl)-dicyclopentadien

di-[2-(3'-tert.butyl-2'-hydroxy-5'-methyl-benzyl)-6-tert.butyl-4-methylphenyl]-terephthalate.

1.5. Benzylcompounds, for example,

1,3,5-tri-(3,5-di-tert.butyl-4-hydroxybenzyl)-2,4,6-trimethyl- benzene-di-(3,5-di-tert.butyl-4-hydroxybenzyl)-sulfide

3,5-di-tert.butyl-4-hydroxybenzyl-mercapto-acetic acid-isooctyl ester

bis-(4-tert.butyl-3-hydroxy-2,6-dimethylbenzyl)dithiol-terephthalate

1,3,5-tris-(3,5-di-tert.butyl-4-hydroxybenzyl)-isocyanurate

1,3,5-tris-(4-tert.butyl-3-hydroxy-2,6-dimethylbenzyl)-isocyanurate

3,5-di-tert.butyl-4-hydroxybenzyl-phosphoric acid-dioctadecyl ester

3,5-di-tert.butyl-4-hydroxybenzyl-phosphoric acid-monoethyl ester, calcium-salt

1.6. Acylaminophenols, for example,

4-hydroxy-lauric acid anilide

4-hydroxy-stearic acid anilide

2,4-bis-octylmercapto-6-(3,5-tert.butyl-4-hydroxyanilino)-s-triazine

octyl-N-(3,5-di-tert.butyl-4-hydroxyphenyl)-carbamidate

1.7. Esters of β-(3,5-di-tert.butyl-4-hydroxyphenyl)-propionic acid with monohydric or polyhydric alcohols, for example,

methanol

octadecanol

1,6-hexanediol

neopentylglycol

thiodiethyleneglycol

diethyleneglycol

triethyleneglycol

pentaerythritol

tris-hydroxyethyl isocyanurate

di-hydroxyethyl oxalic acid

diamide

1.8. Ester of β-(5-tert.butyl-4-hydroxy-3-methylphenyl)propionic acid with monohydric or polyhydric alcohols, for example,

methanol

octadecanol

1,6-hexanediol

neopentylglycol

thiodiethyleneglycol

diethyleneglycol

triethyleneglycol

pentaerytritol

tris-hydroxyethyl isocyanurate

di-hydroxyethyl oxalic acid

diamide

1.9. Amides of β-(3,5-di-tert.butyl-4-hydroxyphenyl)-propionic acid for example,

N,N'-di-(3,5-di-tert.butyl-4-hydroxyphenylpropionyl)-hexamethylendiamine

N,N'-di-(3,5-di-tert.butyl-4-hydroxyphenylpropionyl)-trimethylendiamine

N,N'-di-(3,5-di-tert.butyl-4-hydroxyphenylpropionyl)-hydrazine

2. UV absorbers and light stabilisers

2.1. 2-(2'-Hydroxyphenyl) benzotriazoles, for example, the 5'-methyl-, 3',5'-di-tert.butyl-, 5'-tert.butyl-, 5'-(1,1,3,3-tetramethylbutyl)-, 5-chloro-3',5'-di-tert.butyl-, 5-chloro-3'-tert.butyl-5'-methyl-, 3'-sec.butyl-5'-tert.butyl-, 4'-octoxy-, 3',5'-di-tert.amyl-, 3',5'-bis-(α,α-dimethylbenzyl)-derivative.

2.2 2-hydroxy-benzophenones, for example, the 4-hydroxy-, 4-methoxy-, 4-octoxy, 4-decyloxy-, 4-dodecyloxy-, 4-benzyloxy, 4,2',4'-trihydroxy- and 2'-hydroxy-4,4'-dimethoxyderivative.

2.3. Esters of optionally substituted benzoic acids for example, phenyl salicylate, 4-tert.butyl-phenylsalicilate, octylphenyl salicylate, dibenzoylresorcinol, bis-(4-tert.butylbenzoyl)-resorcinol, benzoylresorcino1,3,5-di-tert.-butyl-4-hydroxybenzoic acid 2,4-di-tert.butyl-phenyl ester and 3,5-di-tert.-butyl-4-hydroxybenzoic acid hexadecyl ester.

2.4. Acrylates, for example, α-cyano-β,β-diphenylacrylic acid ethyl ester or isooctyl ester, α-carbomethoxy-cinnamic acid methyl ester, α-cyano-β-methyl-p-methoxy-cinnamic acid methyl ester or butyl ester, α-carbomethoxy-p-methoxy-cinnamic acid methyl ester, N-(βcarbomethoxy-β-cyanovinyl)-2-methyl-indoline.

2.5 Nickel compounds, for example, nickel complexes of 2,2'-thiobis-[4-(-1,1,3,3-tetramethylbutyl)-phenol], such as the 1:1 or 1:2 complex, optionally with additional ligands such as n-butylamine, triethanolamine or N-cyclohexyl-di-ethanolamine, nickel dibutyldithiocarbamate, nickel salts of 4-hydroxy-3,5-di-tert.butylbenzylphosphonic acid monoalkyl esters, such as of the methyl, ethyl or butyl ester, nickel complexes of ketoximes such as of 2-hydroxy-4-methyl-phenyl undecyl ketonoxime, nickel complexes of 1-phenyl-4-lauroyl-5-hydroxy-pyrazol, optionally with additional ligands.

2.6. Sterically hindered amines, for example bis-(2,2,6,6-tetramethylpiperidyl)-sebacate bis-(1,2,2,6,6-pentamethylpiperidyl)-sebacate n-butyl-3,5-di-tert.butyl-4-hydroxybenzyl malonic acid bis-(1,2,2,6,6-pentamethylpiperidyl)ester, condensation product of 1-hydroxyethyl-2,2,6,6-tetramethyl-4-hydroxypiperidine and succinic acid, condensation product of N,N'-(2,2,6,6-tetramethylpiperidyl)-hexamethylendiamine and 4-tert.octylamino-2,6-dichloro-1,3,5-s-triazine, tris-(2,2,6,6-tetramethylpiperidyl)-nitrilotriacetate, tetrakis-(2,2,6,6-tetramethyl-4-piperidyl)-1,2,3,4-butane-tetracarbonic acid, 1,1'(1,2-ethanediyl)-bis-(3,3,5,5-tetramethylpiperazinone).

2.7. Oxalic acid diamides, for example, 4,4'-di-octyloxy-oxanilide, 2,2'-di-octyloxy-5,5'-di-tert.butyl-oxanilide, 2,2'-di-dodecyloxy5,5'-di-tert.butyl-oxanilide, 2-ethoxy-2'-ethyl-oxanilide, N,N'-bis(3-dimethylaminopropyl)-oxalamide, 2-ethoxy-5-tert.butyl-2'-ethyloxanilide and its mixture with 2-ethoxy-2'-ethyl-5,4'-di-tert.butyloxanilide and mixtures of ortho-and para-methoxy- as well as of o- and p-ethoxy-disubstituted oxanilides.

3. Metal deactivators, for example, N,N'-diphenyloxalic acid diamide, N-salicylal-N'-salicyloylhydrazine, N,N'-bis-salicyloylhydrazine, N,N'-bis-(3,5-di-tert.butyl-4-hydroxyphenylpropionyl)hydrazine, 3-salicyloylamino-1.2,4-triazole, bis-benzyliden-oxalic acid dihydrazide.

4. Phosphites and phosphonites, for example, triphenyl phosphite, diphenylalkyl phosphites, phenyldialkyl phosphites, tri-(nonylphenyl) phosphite, trilauryl phosphite, trioctadecyl phosphite, di-stearyl-pentaerythrit diphosphite, tris-(2,4-di-tert.butylphenyl) phosphite, di-isodecylpentaerythrit diphosphite, di-(2,4-di-tert.butylphenyl)pentaerythrit diphosphite, tristearyl-sorbite triphosphite, tetrakis-(2,4-di-tert.butylphenyl)-4,4'-biphenylylen diphosphonite.

5. Compounds which destroy peroxide, for example, esters of β-thiodipropionic acid, for example the lauryl, stearyl, myristyl or tridecyl esters, mercapto-benzimidazole or the zinc salt of 2-mercaptobenzimidazole, zinc-dibutyl-dithiocarbamate, dioctadecyldisulfide, pentaerythrit-tetrakis-(β-dodecylmercapto)-propionate.

6. Polyamide stabilisers, for example, copper salts in combination with iodides and/or phosphorus compounds and salts of divalent manganese.

7. Basic co-stabilisers, for example, melamine, polyvinylpyrrolidone, dicyandiamide, triallyl cyanurate, urea derivatives, hydrazine derivatives, amines, polyamides, polyurethanes, alkali metal salts and alkaline earth metal salts of higher fatty acids for example Ca stearate, Zn stearate, Mg stearate, Na ricinoleate and K palmitate, antimony pyrocatecholate or zinc pyrocatecholate.

8. Nucleating agents, for example, 4-tert.butyl-benzoic acid, adipic acid, diphenylacetic acid.

9. Fillers and reinforcing agents, for example, calcium carbonate, silicates, glass fibres, asbestos, talc, kaolin, mica, barium sulfate, metal oxides and hydroxydes, carbon black, graphite.

10. Other additives, for example, plasticisers, lubricants, emulsifiers, pigments, optical brighteners, flameproofing agents, antistatic agents and blowing agents.

The efficiency, as stabilisers, of the products prepared according to the present invention is illustrated in the examples which follow, in which the same products obtained in the preparation examples are used for stabilising polypropylene tapes and fibres.

EXAMPLE 9

2 g of each of the products indicated in Table 1, 1 g of pentaerythritol tetrakis-3-(3,5-di-t-butyl-4-hydroxyphenyl)propionate and 1 g of calcium stearate are mixed, in a powder mixer, with 1,000 g of polypropylene powder of melt index 2.4 (® Propathene HF 18, a product of Imperial Chemical Industries).

The mixtures obtained are extruded at a temperature of 180°-220° C., to give polymer granules which are then converted into stretched tapes of 50 μm thickness and 2.5 mm width, under the following working conditions:

extruder temperature: 220°-240° C.

head temperature : 240° C.

stretch ratio : 1:6.

The tapes thus prepared are exposed, mounted on a white card, in a Weather-Ometer 65 WR model (ASTM G 27-70), with a black panel temperature of 63° C.

The residual tenacity is measured on samples, taken after various times of exposure to light, by means of a constant-speed tensometer; the exposure time in hours (T₅₀) needed to halve the initial tenacity is then calculated.

For comparison, polypropylene tapes prepared under the same conditions as indicated above, but without the addition of the compounds of the, are exposed. The results obtained are shown in Table 1:

                  TABLE 1                                                          ______________________________________                                         Stabiliser        T.sub.50 (hours)                                             ______________________________________                                         None                240                                                        Compound of Example 4                                                                            2,370                                                        Compound of Example 5                                                                            1,600                                                        Compound of Example 7                                                                            1,800                                                        ______________________________________                                    

EXAMPLE 10

2.5 g of each of the products indicated in Table 2, 1 g of octadecyl 3-(3,5-di-t-butyl-4-hydroxyphenyl)-propionate, 1 g of calium stearate and 2.5 g of titanium dioxide (® KRONOS RN 57) are mixed, in a powder mixer, with 1,000 g of polypropylene powder of melt index 13 (® Propathene HF 85, a product of Imperial Chemical Industries).

The mixtures are extruded at 180°-220° C., to give polymer granules which are then converted into fibres, under the following working conditions:

extruder temperature: 220°-240° C.

spinneret temperature: 240° C.

stretch ratio: 1:3.5.

count 20 deniers per fibre.

The fibres thus obtained are exposed, mounted on a white card, in a Weather-Ometer 65 WR model with a black panel temperature of 63° C.

The T₅₀ value as described in the preceding example is then calculated.

For comparison, the data obtained with fibres prepared under the same conditions as described above, but without the addition of the compounds of the invention, are also given.

The results obtained are shown in Table 2:

                  TABLE 2                                                          ______________________________________                                         Stabiliser        T.sub.50 (hours)                                             ______________________________________                                         None                120                                                        Compound of Example 4                                                                            1,070                                                        Compound of Example 5                                                                            1,110                                                        Compound of Example 7                                                                            1,050                                                        Compound of Example 8                                                                            1,370                                                        ______________________________________                                    

The data reported above clearly show the stabilising effect obtained with the novel products according to the present invention. 

What is claimed is:
 1. A compound of the formula (I) ##STR23## in which R₁ and R₂ can be identical or different and are hydrogen, C₁ -C₁₈ -alkyl, C₂ -C₁₂ -alkyl substituted by --OH, a C₁ -C₁₈ -alkoxy group or a C₂ -C₁₈ -dialkylamino group, C₃ -C₁₈ -alkenyl, C₅ -C₁₈ -cycloalkyl, C₆ -C₁₈ -aryl, C₇ -C₁₈ -aralkyl or a radical of the formula ##STR24## where R₆ is hydrogen, C₁ -C₁₂ -alkyl, C₃ -C₁₂ -alkenyl or -alkynyl, C₇ -C₁₂ -aralkyl or C₁ -C₁₂ -acyl, or R₁ and R₂, together with the nitrogen atom to which they are bonded, are a heterocylic radical, such as pyrrolidin-1-yl, piperidin-1-yl, hexahydroazepin-1-yl, morpholin-4-yl or 4-methylpiperazin-1-yl, R₃ and R₅ can be identical or different and are radicals of the formula (III), (IV), (V) or (VI) ##STR25## and R₅ additionally can be radical of formula VII ##STR26## wherein R₇ is hydrogen, C₁ -C₆ -alkyl or phenyl, X is a group --O--CH₂)_(n) O-- or --N(R₈)--C(O)--CH₂)_(n) C(O)--N(R₈)--, n is a number between 1 and 6, R₈ has the same meaning as R₁ or R₂ and Y is C₂ -C₁₂ -alkylene, C₃ -C₁₂ -alkylene substituted by one hydroxyl or containing an oxgen atom in the chain, C₄ -C₁₂ -alkenylene or C₈ -C₁₂ aralkylene, R₄ is C₂ -C₁₈ -diacyl or a radical of the formula (VIII) ##STR27## in which R₁ and R₂ are as defined above, a is a number between 0.2 and 1, and b is a number between zero and 0.8; the compounds of the formula (I) have a number average molecular weight Mn between 1,000 and 20,000.
 2. A compound according to claim 1, of the formula (I), in which R₁ and R₂ can be identical or different and are hydrogen, C₁ -C₁₂ -alkyl, C₂ -C₆ -alkyl substituted by C₁ -C₁₂ -alkoxy, C₃ -C₆ alkenyl, C₆ -C₁₀ -cycloalkyl or a radical of the formula (II) in which R₆ is hydrogen, methyl, allyl, benzyl or acetyl, or the radicals R₁ and R₂, together with the nitrogen atom to which they are bonded, are a pyrrolidin-1-yl, piperidin-1-yl, hexahydroazepin-1-yl or morpholin-4-yl radical, R₃ and R₅ are a radical of formula (III) and R₅ additionally can be a radical of formula (VII), R₇ is hydrogen, methyl, or ethyl, Y is C₂ -C₆ -alkylene, but-2-ene-1,4-diyl or xylylene, R₄ is C₂ -C₁₂ -diacyl or a radical of the formula (VIII) in which R₁ and R₂ are as defined above, a is a number between 0.3 and 1, and b is a number between zero and 0.7, and the number average molecular weight Mn is between 1,500 and 10,000.
 3. A compound according to claim 1, of the formula (I), in which R₁ and R₂ can be identical or different and are C₁ -C₁₈ -alkyl, cyclohexyl, 2,2,6,6-tetramethyl-piperidin-4-yl or 1,2,2,6,6-pentamethyl-piperidin-4-yl, R₃ and R₅ are a radical of formula (III) and R₅ additionally can be a radical of formula (VIII), R₇ is hydrogen or methyl, Y is but-2-ene-1,4-diyl or xylylene, a is 1 and b is zero, and the number average molecular weight Mn is between 15,000 and 6,000. 